ClinicalTrials.Veeva

Menu

Selection of Surgical Technique in Rectal Cancer (TECARE)

I

Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta

Status

Enrolling

Conditions

Rectal Neoplasms

Treatments

Other: Data collection

Study type

Observational

Funder types

Other

Identifiers

NCT06442215
2024.017

Details and patient eligibility

About

Currently, there is no prediction scale available to identify patients with rectal neoplasms as technically complex in the middle and lower thirds; that is, those who are at high risk of affected circumferential margins and low quality of the mesorectum. The application of a predictive model that allows preoperative identification of the group of patients in whom optimal results in mesorectal quality and circumferential margin are less likely to be obtained through laparoscopic or minimally invasive surgery would enable the selection of patients who will require and justify all efforts and healthcare resources to improve surgical outcomes.

Therefore, the investigators aim to create a predictive model to identify these patients, allowing the discrimination of which patients will benefit from different techniques, or even which ones would be opportune to initially consider an open approach.

Enrollment

333 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Scheduled surgery for anterior resection of the rectum meeting oncological criteria with mesorectal excision.
  • Age ≥ 18 years.
  • Histology of adenocarcinoma with or without neoadjuvant chemotherapy or chemoradiotherapy.
  • Initial stage T1-T4a. Any N. Any M.
  • Intention for R0 resection.

Exclusion criteria

  • Colorectal tumor with histology different from adenocarcinoma.
  • Synchronous colon tumor.
  • Benign pathology or adenoma.
  • Tis.
  • T4b or oncological multivisceral resections.
  • History of neoplastic colorectal surgery or local excision or TAMIS.
  • Perforated or obstructive rectal neoplasm.

Trial design

333 participants in 1 patient group

Patients undergoing elective surgery for rectal neoplasm
Description:
Patients diagnosed with rectal neoplasia undergoing elective surgery between 2017 and 2021 at medical centers within the national territory.
Treatment:
Other: Data collection

Trial contacts and locations

1

Loading...

Central trial contact

Nuria Ortega, MD; Lidia Cornejo, MSC

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems